Moderna's COVID-19 Is the Only mRNA RSV Vaccine

Pfizer, GSK and Moderna are all working on vaccines for RSV. Pfizer is using a recombinant protein technology while GSK has an adjuvant. We'll have to see how that ends up shaking out as we see more data over time than of course the durability of these vaccines will be a major question also. But we're looking at potentially these getting on the market this year, early next year for Moderna.